Magneto-Electric Nanoparticles for Targeted Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery methods, particularly for HIV and cancer treatments, face challenges in effectively crossing the blood-brain barrier (BBB) due to the instability of nanocarriers and inconsistent drug release kinetics, leading to low bioavailability and incomplete eradication of HIV reservoirs in the CNS.
Innovation Solution
The use of magneto-electric nanoparticles (MENPs) that form ionic bonds with drugs, allowing for controlled release through a magnetic field, enabling targeted and efficient delivery across the BBB by breaking the ionic bond with remote magnetic fields, thereby achieving high-yield drug release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing nanocarriers (polymeric nanoparticles, dendrimers, micelles, liposomes) are used for drug delivery, then drug delivery to CNS is attempted, but the nanocarriers are unstable and produce inconsistent drug release kinetics
Solution Approach 1:
The patent uses a composite nanocarrier system consisting of magnetic nanoparticles (for targeting and magnetic field responsiveness) combined with ionizable lipids (for drug encapsulation and BBB penetration). This composite structure combines the advantages of different materials to achieve both stable drug delivery and controlled release, resolving the contradiction between nanocarrier stability and drug release consistency.
Solution Approach 2:
The patent employs ionizable lipids that change their properties based on pH conditions. In the acidic environment of the BBB and inflamed tissues, the lipids become protonated and more stable, while in neutral pH conditions, they release the drug consistently. This parameter-based control resolves the contradiction by using environmental conditions to regulate both stability and release kinetics.
2Quantity of substance
If nanodrugs are delivered systemically, then drug reaches peripheral tissues, but more than 99% of nanodrugs are deposited in liver, lungs or other lymphoid organs before reaching the brain
Solution Approach 1:
The patent uses magnetic fields as an intermediary force to guide the nanocarriers from peripheral circulation to the brain. By applying external magnetic fields, the magnetic nanoparticles are directed through the BBB to the target site, significantly increasing brain delivery while reducing off-target deposition in liver and lungs.
Solution Approach 2:
The magnetic nanoparticles serve multiple functions: they provide passive targeting through magnetic guidance, active targeting through BBB penetration, and controlled release through magnetic field stimulation. This multi-functionality allows the same carrier system to achieve high drug delivery efficiency while minimizing off-target effects.
3Quantity of substance
If drug is delivered across BBB using existing methods, then some drug reaches the brain, but the integrity of BBB is compromised or drug release is inconsistent
Solution Approach 1:
The patent replaces mechanical disruption methods (which physically compromise BBB integrity) with magnetic field-based control. The magnetic fields provide non-invasive guidance and control of drug release, maintaining BBB integrity while achieving efficient drug delivery to the brain.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for nearly 100% efficient drug release and targeted delivery to the brain, overcoming the limitations of existing nanocarriers by using magnetic fields to control the electric field bonding between MENPs and drugs, ensuring effective treatment of HIV and cancer without compromising the BBB's integrity.
Implementation Method 1
applying a magnetic field to the subject to weaken the ionic bond thereby releasing at least a portion of the drug from the MENP
Data Source
AI summary
Disclosed herein are methods of delivering drugs to a subject in a controlled release fashion by administering a magneto-electric nanoparticle having ionic bonds to a drug then applying a magnetic field to weaken the ionic bonds and release the drug.